Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James M Cook

Showing results (261-270 of 329) with videos related to

Pageof 33
Sort By:
Frontiers in Pharmacology|December 7, 2016
Sex-Dependent Anti-Stress Effect of an α5 Subunit Containing GABA<sub>A</sub> Receptor Positive Allosteric ModulatorSean C Piantadosi, Beverly J French, Michael M Poe, et al.
International Journal of Medicinal Chemistry|December 19, 2015
A Review of the Updated Pharmacophore for the Alpha 5 GABA(A) Benzodiazepine Receptor ModelTerry Clayton, Michael M Poe, Sundari Rallapalli, et al.
Frontiers in Behavioral Neuroscience|October 31, 2009
The alpha1 subunit of the GABA(A) receptor modulates fear learning and plasticity in the lateral amygdalaBrian J Wiltgen, Bill P Godsil, Zechun Peng, et al.
Pharmacology, Biochemistry, and Behavior|January 18, 2022
The imidazodiazepine, KRM-II-81: An example of a newly emerging generation of GABAkines for neurological and psychiatric disordersJeffrey M Witkin, Arnold Lippa, Jodi L Smith, et al.
Plos Neglected Tropical Diseases|November 16, 2019
Non-sedating benzodiazepines cause paralysis and tissue damage in the parasitic blood fluke Schistosoma mansoniPaul McCusker, Md Yeunus Mian, Guanguan Li, et al.
Pharmaceutics|February 26, 2025
Intravenous Nanoemulsions Loaded with Phospholipid Complex of a Novel Pyrazoloquinolinone Ligand for Enhanced Brain DeliveryTijana Stanković, Tanja Ilić, Branka Divović Matović, et al.
Bioorganic & Medicinal Chemistry|December 11, 2012
Search for α3β₂/₃γ2 subtype selective ligands that are stable on human liver microsomesOjas A Namjoshi, Zhi-jian Wang, Sundari K Rallapalli, et al.
Nuclear Receptor Research|November 25, 2014
IDENTIFICATION OF VDR ANTAGONISTS AMONG NUCLEAR RECEPTOR LIGANDS USING VIRTUAL SCREENINGKelly Teske, Premchendar Nandhikonda, Jonathan W Bogart, et al.
Brain Research|August 2, 2019
The value of human epileptic tissue in the characterization and development of novel antiepileptic drugs: The example of CERC-611 and KRM-II-81Jeffrey M Witkin, Xingjie Ping, Rok Cerne, et al.
International Journal of Pharmaceutics|January 19, 2023
High amount of lecithin facilitates oral delivery of a poorly soluble pyrazoloquinolinone ligand formulated in lipid nanoparticles: Physicochemical, structural and pharmacokinetic performancesJelena R Mitrović, Branka Divović-Matović, Daniel E Knutson, et al.
Pageof 33

Showing results (261-270 of 329) with videos related to

Sort By:
Pageof 33
Frontiers in Pharmacology|December 7, 2016
Sex-Dependent Anti-Stress Effect of an α5 Subunit Containing GABA<sub>A</sub> Receptor Positive Allosteric ModulatorSean C Piantadosi, Beverly J French, Michael M Poe, et al.
International Journal of Medicinal Chemistry|December 19, 2015
A Review of the Updated Pharmacophore for the Alpha 5 GABA(A) Benzodiazepine Receptor ModelTerry Clayton, Michael M Poe, Sundari Rallapalli, et al.
Frontiers in Behavioral Neuroscience|October 31, 2009
The alpha1 subunit of the GABA(A) receptor modulates fear learning and plasticity in the lateral amygdalaBrian J Wiltgen, Bill P Godsil, Zechun Peng, et al.
Pharmacology, Biochemistry, and Behavior|January 18, 2022
The imidazodiazepine, KRM-II-81: An example of a newly emerging generation of GABAkines for neurological and psychiatric disordersJeffrey M Witkin, Arnold Lippa, Jodi L Smith, et al.
Plos Neglected Tropical Diseases|November 16, 2019
Non-sedating benzodiazepines cause paralysis and tissue damage in the parasitic blood fluke Schistosoma mansoniPaul McCusker, Md Yeunus Mian, Guanguan Li, et al.
Pharmaceutics|February 26, 2025
Intravenous Nanoemulsions Loaded with Phospholipid Complex of a Novel Pyrazoloquinolinone Ligand for Enhanced Brain DeliveryTijana Stanković, Tanja Ilić, Branka Divović Matović, et al.
Bioorganic & Medicinal Chemistry|December 11, 2012
Search for α3β₂/₃γ2 subtype selective ligands that are stable on human liver microsomesOjas A Namjoshi, Zhi-jian Wang, Sundari K Rallapalli, et al.
Nuclear Receptor Research|November 25, 2014
IDENTIFICATION OF VDR ANTAGONISTS AMONG NUCLEAR RECEPTOR LIGANDS USING VIRTUAL SCREENINGKelly Teske, Premchendar Nandhikonda, Jonathan W Bogart, et al.
Brain Research|August 2, 2019
The value of human epileptic tissue in the characterization and development of novel antiepileptic drugs: The example of CERC-611 and KRM-II-81Jeffrey M Witkin, Xingjie Ping, Rok Cerne, et al.
International Journal of Pharmaceutics|January 19, 2023
High amount of lecithin facilitates oral delivery of a poorly soluble pyrazoloquinolinone ligand formulated in lipid nanoparticles: Physicochemical, structural and pharmacokinetic performancesJelena R Mitrović, Branka Divović-Matović, Daniel E Knutson, et al.
Pageof 33